Table of Contents
Journal of Amino Acids
Volume 2015 (2015), Article ID 481517, 8 pages
http://dx.doi.org/10.1155/2015/481517
Research Article

The Association of Endothelin-1 with Markers of Arterial Stiffness in Black South African Women: The SABPA Study

1Hypertension in Africa Research Team (HART), North-West University, Potchefstroom 2531, South Africa
2Medical Research Council, Research Unit for Hypertension and Cardiovascular Disease, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa

Received 15 October 2015; Revised 26 November 2015; Accepted 1 December 2015

Academic Editor: Hieronim Jakubowski

Copyright © 2015 Christine Susara du Plooy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. S. Celermajer, K. E. Sorensen, D. J. Spiegelhalter, D. Georgakopoulos, J. Robinson, and J. E. Deanfield, “Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women,” Journal of the American College of Cardiology, vol. 24, no. 2, pp. 471–476, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Kalinowski, I. T. Dobrucki, and T. Malinski, “Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases,” Circulation, vol. 109, no. 21, pp. 2511–2517, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. E. Schutte, H. W. Huisman, R. Schutte et al., “Arterial stiffness profiles: investigating various sections of the arterial tree of African and caucasian people,” Clinical and Experimental Hypertension, vol. 33, no. 8, pp. 511–517, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. O'Rourke, “Arterial stiffness, systolic blood pressure and logical treatment of arterial hypertension,” Hypertension, vol. 15, no. 4, pp. 339–347, 1990. View at Publisher · View at Google Scholar · View at Scopus
  5. M. E. Safar, B. I. Levy, and H. A. J. Struijker-Boudier, “Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases,” Circulation, vol. 107, no. 22, pp. 2864–2869, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. S. J. Zieman, V. Melenovsky, and D. A. Kass, “Mechanisms, pathophysiology, and therapy of arterial stiffness,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 5, pp. 932–943, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Böhm and J. Pernow, “The importance of endothelin-1 for vascular dysfunction in cardiovascular disease,” Cardiovascular Research, vol. 76, no. 1, pp. 8–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. W. G. Haynes and D. J. Webb, “Contribution of endogenous generation of endothelin-1 to basal vascular tone,” The Lancet, vol. 344, no. 8926, pp. 852–854, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. T. J. Anderson, “Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk,” Canadian Journal of Cardiology, vol. 22, pp. 72B–80B, 2006. View at Google Scholar · View at Scopus
  10. Y. Dohi and T. F. Luscher, “Aging differentially affects direct and indirect actions of endothelin-1 in perfused mesenteric arteries of the rat,” British Journal of Pharmacology, vol. 100, no. 4, pp. 889–893, 1990. View at Publisher · View at Google Scholar · View at Scopus
  11. A. J. Donato, L. B. Gano, I. Eskurza et al., “Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 297, no. 1, pp. H425–H432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Goettsch, T. Lattmann, K. Amann et al., “Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis,” Biochemical and Biophysical Research Communications, vol. 280, no. 3, pp. 908–913, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Komatsumoto and M. Nara, “Changes in the level of endothelin-1 with aging,” Japanese Journal of Geriatrics, vol. 32, no. 10, pp. 664–669, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Heintz, R. Dörr, T. Gillessen et al., “Do arterial endothelin 1 levels affect local arterial stiffness?” American Heart Journal, vol. 126, no. 4, pp. 987–989, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. C. M. McEniery, A. Qasem, M. Schmitt, A. P. Avolio, J. R. Cockcroft, and I. B. Wilkinson, “Endothelin-1 regulates arterial pulse wave velocity in vivo,” Journal of the American College of Cardiology, vol. 42, no. 11, pp. 1975–1981, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Browatzki, J. Schmidt, W. Kübler, and R. Kranzhöfer, “Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-kappaB in human vascular smooth muscle cells,” Basic Research in Cardiology, vol. 95, no. 2, pp. 98–105, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Iwasa, J. Fan, T. Shimokama, M. Nagata, and T. Watanabe, “Increased immunoreactivity of endothelin-1 and endothelin-B receptor in human atherosclerotic lesions. A possible role in atherogenesis,” Atherosclerosis, vol. 146, no. 1, pp. 93–100, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Libby, P. M. Ridker, and A. Maseri, “Inflammation and atherosclerosis,” Circulation, vol. 105, no. 9, pp. 1135–1143, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Ergul, K. Shoemaker, D. Puett, and R. L. Tackett, “Gender differences in the expression of endothelin receptors in human saphenous veins in vitro,” Journal of Pharmacology and Experimental Therapeutics, vol. 268, pp. 611–617, 1998. View at Google Scholar
  20. A. Ergul, “Hypertension in black patients: an emerging role of the endothelin system in salt-sensitive hypertension,” Hypertension, vol. 36, pp. 62–67, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Ergul, D. C. Parish, D. Puett, and A. Ergul, “Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension,” Hypertension, vol. 28, no. 4, pp. 652–655, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Malan, M. Hamer, N. Frasure-Smith, H. S. Steyn, and N. T. Malan, “Cohort profile: sympathetic activity and ambulatory blood pressure in Africans (SABPA) prospective cohort study,” International Journal of Epidemiology, 2014. View at Publisher · View at Google Scholar
  23. M. Marfell-Jones, T. Olds, A. Stewart, and L. Carter, International Standards for Anthropometric Assessment, ISAK, Potchefstroom, South Africa, 2006.
  24. American College of Sports Medicine (ACSM), Guidelines for Exercise Testing and Prescription, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 7th edition, 2006.
  25. K. H. Wesseling, J. R. C. Jansen, J. J. Settels, and J. J. Schreuder, “Computation of aortic flow from pressure in humans using a nonlinear, three-element model,” Journal of Applied Physiology, vol. 74, no. 5, pp. 2566–2573, 1993. View at Google Scholar · View at Scopus
  26. M. W. Bernadt, C. Taylor, J. Mumford, B. Smith, and R. M. Murray, “Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism,” The Lancet, vol. 319, no. 8267, pp. 325–328, 1982. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Connor Gorber, S. Schofield-Hurwitz, J. Hardt, G. Levasseur, and M. Tremblay, “The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status,” Nicotine and Tobacco Research, vol. 11, no. 1, pp. 12–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  29. W. F. Keane, G. Eknoyan, and K. Willis, “Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the national kidney foundation,” American Journal of Kidney Diseases, vol. 33, no. 5, pp. 1004–1011, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Faul, E. Erdfelder, A. Buchner, and A.-G. Lang, “Statistical power analyses using G power 3.1: tests for correlation and regression analyses,” Behavior Research Methods, vol. 41, pp. 1149–1160, 2009. View at Google Scholar
  31. C. Cardillo, C. M. Kilcoyne, M. Waclawiw, R. O. Cannon III, and J. A. Panza, “Role of endothelin in the increased vascular tone of patients with essential hypertension,” Hypertension, vol. 33, no. 2, pp. 753–758, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Ergul, “Endothelin-1 and diabetic complications: focus on the vasculature,” Pharmacological Research, vol. 63, no. 6, pp. 477–482, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. F. A. Treiber, G. K. Kapuku, H. Davis, J. S. Pollock, and D. M. Pollock, “Plasma endothelin-1 release during acute stress: role of ethnicity and sex,” Psychosomatic Medicine, vol. 64, no. 5, pp. 707–713, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Amiri, A. Virdis, M. F. Neves et al., “Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction,” Circulation, vol. 110, no. 15, pp. 2233–2240, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Ergul, “Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents,” Pharmacotherapy, vol. 22, no. 1, pp. 54–65, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Ergul, A. Ergul, J. A. Hudson et al., “The effect of regulation of high blood pressure on plasma endothelin-1 levels in blacks with hypertension,” American Journal of Hypertension, vol. 11, no. 11, pp. 1381–1385, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. D. E. Kohan, N. F. Rossi, E. W. Inscho, and D. M. Pollock, “Regulation of blood pressure and salt homeostasis by endothelin,” Physiological Reviews, vol. 91, no. 1, pp. 1–77, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. P. Schneider, E. I. Boesen, and D. M. Pollock, “Contrasting actions of endothelin ETA and ETB receptors in cardiovascular disease,” Annual Review of Pharmacology and Toxicology, vol. 47, pp. 731–759, 2007. View at Publisher · View at Google Scholar
  39. J. D. Cameron, C. J. Bulpitt, E. S. Pinto, and C. Rajkumar, “The aging of elastic and muscular arteries: a comparison of diabetic and nondiabetic subjects,” Diabetes Care, vol. 26, no. 7, pp. 2133–2138, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Smith, Soluble urokinase plasminogen activator receptor and cardiovascular function in African and Caucasian populations: the SAfrEIC study [M.S. thesis], North-West University, Potchefstroom, South Africa, 2010, http://hdl.handle.net/10394/4950.
  41. A. E. Schutte, D. van Vuuren, J. M. van Rooyen et al., “Inflammation, obesity and cardiovascular function in African and Caucasian women from South Africa: the POWIRS study,” Journal of Human Hypertension, vol. 20, no. 11, pp. 850–859, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Verma, S.-H. Li, M. V. Badiwala et al., “Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein,” Circulation, vol. 105, no. 16, pp. 1890–1896, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Wassmann, M. Stumpf, K. Strehlow et al., “Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor,” Circulation Research, vol. 94, no. 4, pp. 534–541, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. S. M. Grundy, “Obesity, metabolic syndrome and coronary atherosclerosis,” Circulation, vol. 105, no. 23, pp. 2696–2698, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Tomás, G. Latorre, M. Sentí, and J. Marrugat, “The antioxidant function of high density lipoproteins: a new paradigm in atherosclerosis,” Revista Espanola de Cardiologia, vol. 57, no. 6, pp. 557–569, 2004. View at Publisher · View at Google Scholar · View at Scopus